Conference Coverage

Veracyte Inc. announced that new data being presented at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting suggest the company’s Decipher Prostate genomic classifier identifies patients with clinically high-risk prostate cancer who may require treatment intensification beyond standard-of-care therapy
News | Prostate Cancer
Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer

November 11, 2021 — Veracyte Inc. announced that new data being presented at the American Society for Radiation Oncology ...

Time November 11, 2021
arrow
Videos | Radiation Therapy
VIDEO: Examples of a Flexible Custom Bolus for EBRT

An example of flexible bolus made from silicone on molds that were 3-D printed from patient CT scans. These are very ...

Time November 11, 2021
arrow
Videos | Radiation Therapy
VIDEO: Examples of Cherenkov Radiation Imaging During Radiation Therapy

DoseOptic gained FDA clearance in 2020 for its Cherenkov radiation imaging system for use during radiation therapy ...

Time November 11, 2021
arrow
Steven Chmura, M.D., Ph.D., University of Chicago, speaks at an ASTRO 2021 press conference on the results of a phase 1 clinical trial testing the effects of stereotactic body radiotherapy for treating multiple metastases. His study determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases. Read more on this study.
Feature | ASTRO
Radiation Oncology Research Featured at ASTRO 2021

November 8, 2021 — The following links to all the highlighted sessions presented at the American Society for Radiation ...

Time November 08, 2021
arrow
A radiotherapy treatment plan for Accuray’s Tomotherapy system to kill white blood cells prior to a liver cancer patient undergoing a transplant. The treatment is aimed at the bone marrow and spares dose to most of the organs to reduce side effects. This was an example plan created on the new Volvo Ultra treatment planning system. The software allow planning for more than 100 cm of anatomy. It also allows users to drag target dose values of the main graph and the system will recalculate all the doses.
Gallery | ASTRO | By Dave Fornell, ITN Editor
Photo Gallery of Technologies at ASTRO 2021

This is an image gallery of technologies on display on the expo floor at the 2021 American Society of Radiation Oncology ...

Time November 08, 2021
arrow
recent research on personalized treatment for HPV-associated oropharyngeal cancer – particularly for patients with an inherited variant KRAS gene
News | Radiation Oncology
Identifying Unique Genetic Variants to Overcome Cancer Treatment Barriers

November 5, 2021 — Robert Chin, M.D., Ph.D., a radiation oncologist with UCLA Jonsson Comprehensive Cancer Center, will ...

Time November 05, 2021
arrow
Enterprise imaging vendors are releasing completely new, revamped platforms that are programmed from the ground up as web-based platforms, rather than older architecture systems that were modified to be used as cloud-based systems
Feature | Enterprise Imaging | By Dave Fornell
4 Trends in Enterprise Imaging Systems

Here is a list of some of the top overarching trends in enterprise radiology systems the editors of Imaging Technology ...

Time November 05, 2021
arrow
Canon's Vitrea PACS enterprise imaging system was one of several systems demonstrated at HIMSS 2021 that had easily modified hanging protocols. This included ease of use to customize what each radiologists prefers, including slice thickness. #HIMSS #HIMSS21
Feature | Enterprise Imaging
Advances in PACS and Enterprise Imaging Systems at HIMSS 2021

Taking advantage of new technology advances, several radiology PACS, enterprise imaging and cardiovascular information ...

Time November 04, 2021
arrow
The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura Dawson, MD, FASTRO, Chair of the ASTRO Board of Directors, in response to the 2022 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules announced by the Centers for Medicare and Medicaid Services (CMS)
News | Radiation Oncology
ASTRO Deeply Concerned and Disappointed Over CMS 2022 Final Rules

November 3, 2021 — The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura ...

Time November 03, 2021
arrow
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.
Feature | Radiology Business | Melinda Taschetta-Millane
Top 10: Most Popular Radiology Technology Content in October 2021

November 2, 2021 — Here is a list of the Top 10 most popular pieces of content on ITNonline.com from the month of ...

Time November 02, 2021
arrow
FLASH therapy, powered by the use of Varian’s ProBeam, is an experimental treatment modality delivering radiation therapy at ultra-high dose rates, in typically less than one second.
News | Proton Therapy
Varian and the Cincinnati Children's/UC Health Proton Therapy Center Complete Enrollment of FAST-01

November 2, 2021 — Varian, a Siemens Healthineers company, and the Cincinnati Children's/UC Health Proton Therapy Center ...

Time November 02, 2021
arrow
Philips will demonstrate its Multimodality RT Simulation Workspace, a precision medicine application that provides a vendor-agnostic single space for simulation, multimodality image fusion and contouring
News | ASTRO
Philips Highlights New Patient-centered Innovations at ASTRO 2021

November 2, 2021 — Philips announced new innovations that can help improve cancer care across the patient journey at the ...

Time November 02, 2021
arrow
Data presented demonstrates use of DCISionRT and its response subtype (Rst) was able to identify women with ductal carcinoma in situ (DCIS)  (Stage 0 breast cancer) who remain at an elevated risk of recurrence despite receiving breast conserving surgery (BCS) and radiation therapy (RT).
News | Radiation Therapy
PreludeDx Presents DCIS Precision Medicine Study Results at ASTRO 2021 Annual Meeting

November 2, 2021 — Prelude Corporation, a leader in molecular diagnostics and precision medicine for early-stage breast ...

Time November 02, 2021
arrow
18F-FDG PET in patients with long-COVID syndrome. A and B: Transaxial sections of group averaged, spatially normalized 18F-FDG PET scans in patients with long-COVID syndrome (A) and control patients (B). C: The pattern expression score (PES; *adjusted for age and sex, for illustration purposes) of the previously established COVID-19-related spatial covariance pattern was not significantly different between patients with long-COVID syndrome and control patients. Boxplots (grey), as well as individual values
News | Coronavirus (COVID-19)
Molecular Imaging Suggests Long-COVID Symptoms may be Caused by Fatigue

November 1, 2021 — Long-term cognitive problems after a COVID-19 diagnosis may be a result of fatigue rather than ...

Time November 01, 2021
arrow
News | Stereotactic Body Radiation Therapy (SBRT)
Serial Radiation Therapy is Safe and Effective as Alternative Treatment to Systemic Therapy for Kidney Cancer

October 29, 2021 — In a new single-arm study, researchers at The University of Texas MD Anderson Cancer Center reported ...

Time October 29, 2021
arrow
Elekta Harmony radiation therapy system at ASTRO 2021.
360 Photos | Radiation Therapy
360 Degree View of the Harmony Radiation Therapy System at ASTRO 2021

This is a virtual tour of the New Elekta Harmony radiation therapy system at the American Society of Radiation Oncology ...

Time October 28, 2021
arrow
In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found that dose-equivalent preoperative radiation therapy for extremity/trunk soft tissue sarcoma delivered in five days rather than over the conventional five weeks produced similar benefits and treatment side effects.
News | Radiation Therapy
Optimizing Preoperative Radiation Therapy in High-risk Sarcoma

October 28, 2021 — In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found ...

Time October 28, 2021
arrow
An individual patient data (IPD) meta-analysis of randomized, controlled clinical trials provides strong evidence for the addition of androgen deprivation therapy (ADT) to definitive radiotherapy (RT) for the treatment of prostate cancer, with the projection that adding ADT to the treatment of 10-15 men would prevent the development of distant metastasis in one man.
News | Prostate Cancer
International Meta-analysis Quantifies Impact of Three Prostate Cancer Therapy Intensification Strategies

October 28, 2021 — An individual patient data (IPD) meta-analysis of randomized, controlled clinical trials provides ...

Time October 28, 2021
arrow
ViewRay, Inc. announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with MRIdian SMART (MR-guided stereotactic adaptive radiation therapy) were presented as part of the Annual Meeting of the American Society for Radiation Oncology (ASTRO), the world's largest radiation oncology society, held October 24-27, 2021 in Chicago.
News | Stereotactic Body Radiation Therapy (SBRT)
New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients

October 28, 2021 — ViewRay, Inc. announced that the results of a multi-center study of 148 inoperable pancreatic cancer ...

Time October 28, 2021
arrow
Prevencio, Inc. presented data demonstrating that its artificial intelligence (AI) driven HART CVE blood test scores strongly correlate with subsequent adverse cardiac events in lung cancer patients undergoing radiation treatment.
News | Treatment Planning
Prevencio and Memorial Sloan Kettering Cancer Center Data Demonstrates Significant Correlation of AI-driven HART CVE Blood Test Scores with Development of Adverse Heart Events Following Cancer Radiation Treatment

October 27, 2021 — Prevencio, Inc. presented data demonstrating that its artificial intelligence (AI) driven HART CVE ...

Time October 27, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now